Resverlogix Corp. (TSE:RVX – Get Free Report) crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of C$0.10 and traded as low as C$0.10. Resverlogix shares last traded at C$0.11, with a volume of 88,120 shares changing hands.
Resverlogix Stock Up 4.8%
The company has a debt-to-equity ratio of -10.95, a current ratio of 0.13 and a quick ratio of 0.04. The firm has a 50-day moving average of C$0.10 and a 200 day moving average of C$0.10. The stock has a market capitalization of C$31.61 million, a price-to-earnings ratio of -3.67 and a beta of 0.70.
Resverlogix (TSE:RVX – Get Free Report) last announced its quarterly earnings data on Thursday, November 13th. The biotechnology company reported C$0.00 earnings per share (EPS) for the quarter. As a group, sell-side analysts forecast that Resverlogix Corp. will post -0.22 earnings per share for the current fiscal year.
About Resverlogix
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Recommended Stories
- Five stocks we like better than Resverlogix
- Is THIS the Next Big Money Rush?
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
